Mesenchymal Stem Cell Treatment Shows Promise for Managing Perianal Fistulas in Crohn’s Disease
A study demonstrates that adipose-derived mesenchymal stem cell therapy offers significant improvements in managing perianal fistulas in Crohn’s disease, with high clinical remission rates and a reassuring safety profile.
